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Abstract 
Staphylococcal -toxin is a primarily hydrophilic molecule that binds as a monomer to target membranes and then aggregates toform 
amphiphilic oligomers that represent water-filled transmembrane channels. Current evidence indicates that a region located in the center 
of the molecule inserts deeply into the bilayer. In the present study, we sought o determine whether membrane insertion was triggered by 
the oligomerization process, and whether insertion correlated with pore formation. Double mutants of a-toxin were prepared in which 
His-35 was replaced by Arg, and cysteine residues were introduced at positions 69, 130 and 186. Substitution of His-35 with Arg 
rendered the toxin molecules incapable of proper oligomerization, sothat they remained in nonlytic form after binding to membranes. The 
sulfhydryl groups were labelled with the polarity-sensitive fluorescent dye acrylodan. Functionally intact, single mutant toxins containing 
only the cysteine residues were utilized as controls. Measurements of the fluorescence emission spectrum of acrylodan were performed 
for the active and inactive a-toxin mutants in free solution and in membrane-bound form. The collective results demonstrate hat proper 
oligomerization is required for membrane insertion of the central region in the a-toxin molecule, and that lack of insertion correlates with 
absence of pore formation. 
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1. Introduction 
Staphylococcal o~-toxin was the first pore-forming bac- 
terial toxin to be described [ 1,2] and, with aerolysin, today 
represents the best-studied prototype of an oligomerizing, 
membrane-damaging cytolysin. The toxin is secreted by S. 
aureus  as a water-soluble monomer of M r 34 000 contain- 
ing no cysteine residues [3]. Binding to target membranes 
can occur via a high affinity interaction with an unidenti- 
fied receptor, or via low affinity, non-specific absorption 
to the lipid bilayer [4-6]. In both cases, toxin molecules 
Abbreviations: $69C~ c~-toxin mutant with cysteine instead of serine 
at position 69. Analogous designations were used for the other mutants as 
well; SDS-PAGE, sodium dodecylsulfate polyacrylamide gel elec- 
trophoresis; EM, electron microscopy; BSA, bovine serum albumin; PBS, 
phosphate-buffered saline; DTT, dithiothreitol; EDTA, ethylenediamine- 
tetraacetic acid; EYPC, egg yolk phosphatidylcholine; EYPG, egg yolk 
phosphatidylglycerol; DOC, sodium deoxycholate; Tris, trishydroxymeth- 
ylaminomethane; CD, circular dichroism. 
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diffuse laterally in the membrane plane, ultimately collid- 
ing to form oligomeric ring structures. These were previ- 
ously estimated to consist of six subunits [2], but a recent 
work indicates that they may in fact be heptamers [7]. 
These oligomers are stable in SDS at low temperature but 
can be dissociated by boiling in this detergent [2]. That 
correct oligomerization is required for pore formation is 
supported by two main lines of evidence. First, the process 
of membrane binding can be dissociated from oligomer 
formation at low temperature, and absence of oligomers 
correlates with absence of hemolytic activity [6]. Second, 
proper oligomerization can be abrogated by replacement of 
His-35 with Arg (or with other amino acids). Although 
such mutants till bind normally to target membranes, they 
are devoid of pore-forming capacity [8]. Aberrant oligomers 
are visible by they are detergent-sensitive and can no 
longer be detected by SDS-PAGE. 
To identify the membrane-inserting regions in o~-toxin, 
we are analyzing mutant oxins containing cysteine residues 
at defined positions to which the polarity-sensitive dye 
acrylodan can be attached. The fluorescence mission 
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spectrum of acrylodan reveals whether the dye is in a 
hydrophilic or hydrophobic environment [9-11]. We re- 
cently obtained evidence that Cys-130, located quite pre- 
cisely in the center of the toxin molecule, inserts deeply 
into the lipid bilayer during oligomer formation [12]. That 
this molecular egion is directly involved in the channel- 
forming activity of a-toxin has been demonstrated by 
replacement of amino acids 130 through 134 with histidine 
which rendered the toxin channels sensitive to blocking 
with zinc ions [13]. Consistent with the view that this 
region lines the inner surface of the channel is the accessi- 
bility of an engineered cysteine in position 129 to sulfhydryl 
specific reagents [14]. 
In contrast, acrylodan attached to $69C exhibited no 
change in fluorescence emission spectrum upon oligomer- 
ization, and this region hence would be expected not to 
penetrate into the membrane. Both of these findings were 
corroborated by measurements of fluorescence nergy 
transfer to labelled membrane phospholipids [12]. More- 
over, biotin attached to $69C and S186C in membrane 
bound oligomers was accessible to fluorescently-labelled 
streptavidin [15]. 
In the present study, we conducted experiments with 
single and double mutants of a-toxin with several ques- 
tions in mind. First, does the shift in emission spectrum of 
acrylodan attached to Cys-130 truly reflect interaction with 
lipid? Second, is proper oligomerization a prerequisite for 
the insertion of Cys-130 into the bilayer? Related to this is 
the decisive question of whether insertion of Cys-130 
correlates with pore formation. The affirmative results 
obtained in this study support the hypothesis that the 
central molecular domain of c~-toxin is directly involved in 
forming the wall of the transmembrane pore. 
2.3. Labelling of sulfhydryl groups 
Labelling with biotin maleimide (Sigma) or acrylodan 
(Molecular Probes, Eugene, USA): proteins were trans- 
ferred into degassed PBS with 1 mM EDTA (PBS/EDTA) 
using PDI0 columns (Pharmacia), and a 5-fold molar 
excess of reagent was immediately added. After 15 min 
(biotin) or 2 h (acrylodan), DTT was added to 5 mM and 
unbound label removed by gel filtration. Acrylodan la- 
belling was evident on UV-transilluminated SDS-gels. 
H35R a-toxin (which contains no cysteine) was not de- 
tectably labelled. 
2.4. Protection against hemolysis by mutant oxins 
Mutant toxins in PBS/EDTA were pre-incubated with 
several SH-reagents at room temperature for 15 rain and 
serial 2-fold dilutions were prepared in PBS containing 
0.1% BSA. Rabbit erythrocytes were added to 2.108 
cells/ml. After incubation for 60 rain at room temperature, 
wild-type c~-toxin was added to 5 /xg/ml. Following a 
second incubation for 60 min, the lowest concentration f
mutant oxin that completely inhibited hemolysis was de- 
termined by visual reading. H35R toxin and unlabelled 
double mutants were used for comparison [8]. 
2.5. Liposome preparation 
EYPC, EYPG and cholesterol (FLUKA; molar ratio 
5:1:4) were dried down from chloroform/methanol (2:1, 
v /v)  with N 2 and resuspended in PBS. Liposomes were 
prepared by ultrasonication (10 min with a Branson probe 
sonifier 250, output scale set to 40) and used directly. 
2. Materials and methods 2.6. Binding of a-toxin to liposomes 
2.1. Plasmid constructions 
A derivative of plasmid pDU1212 [16] carrying the 
mutation H35R [8] was cut with Kpnl and the digest 
retransfected into Escherichia coli TG1, which resulted in 
deletion of an internal 660 bp fragment from the a toxin 
gene. This fragment was replaced by the corresponding 
ones carrying the cysteine codons introduced earlier [15]. 
2.2. Toxin isolation 
Acrylodan-labelled toxins were incubated with lipo- 
somes at room temperature. After 45 min, liposomes were 
collected in a Beckman airfuge (100000 X g, 10 min). 
They were resuspended in PBS and used for fluorimetry, 
and also analyzed by SDS-PAGE with visualization of 
labelled proteins by an UV-lamp. 
2.7. Preparation of delipidated acrylodan-labelled 130C-a 
toxin oligomers 
Wild-type a-toxin and mutant oxins were isolated as 
described [15]. Briefly, the a toxin-negative S. aureus 
strain DU 1090 [17] was transfected with the plasmids and 
grown in 2 X TY broth. The culture supernatants were 
concentrated by membrane filtration and the mutant oxins 
purified by ion exchange chromatography on S-Sepharose 
HR (Pharmacia). Proteins were stored with 5 mM DTT at 
- 70 ° C. 
Liposomes were incubated with labelled 130C-c~-toxin 
to generate membrane-bound oligomers. The liposomes 
were solubilized with 125 mM DOC and applied to a 
Sephacryl S-300 column equilibrated with 6.25 mM DOC, 
150 mM NaC1, 20 mM Tris, pH 8.3 to separate oligomers 
from lipids and residual monomers. Fractions containing 
the oligomers were collected, checked for purity on SDS 
gels and used for fluorimetry. 
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2.8. Spectroscopy A 
Acrylodan emission spectra were recorded in a Hitachi 
2001F fluorometer (excitation wavelength 336 nm; excita- 
tion and emission bandpass 5 nm). All buffers and lipo- 
some preparations were checked for absence of significant 
fluorescence. 
200 kd 
3. Results 
3.1. Characterization of double a-toxin mutants 
The single mutant H35R has previously been shown to 
bind normally to membranes, but not to form SDS-stable 
oligomers [8]. This mutant is also totally devoid of 
hemolytic activity. We produced three double mutants, 
H35RG130C, H35RS69C, and H35RS186C, and first as- 
certained that these mutant toxins were endowed with 
similar properties as the single mutant H35R. All three 
mutants were found to be entirely devoid of hemolytic 
activity. To confirm that binding properties were intact, 
protection experiments were performed in which rabbit 
erythrocytes were first incubated with the toxin mutants 
and then exposed to 5 /~g/ml wild-type toxin. The under- 
lying rationale was that total blockade of the high affinity 
binding sites should occur at approx. 10 /xg/ml, provided 
that the binding affinity of the mutant protein remained 
unaltered. This contention was verified in a previous tudy 
by the use of radio-immunoassays [8].
As shown in Table 1, all three double mutants indeed 
mimicked the single H35R mutant in their protective ca- 
pacity. Furthermore, this property was not affected when 
the sulfhydryl group in the 130C mutant was derivatized 
with biotin, fluorescein or acrylodan, and only partially 
affected when the other two double mutants were deriva- 
Table 1 
Concentrations of single and double a-toxin mutants conferring protec- 
tion against hemolysis by wild-type toxin on rabbit erythrocytes 
Toxin Modification Toxin concentration 
(/zg/ml) 
H35R 10 
H35RS69C 10 
H35RS69C biotin-maleimide 20 
H35RS69C acrylodan 20 
H35RS69C fluorescein-maleimide 40 
H35RG 130C 10 
H35RG 130C biotin-maleimide 10 
H35RG130C acrylodan 10 
H35RGI30C fl uorescein-maleimide 10 
H35RS 186C 10 
H35RS 186C biotin-maleimide 20 
H35RS 186C acrylodan 20 
H35RS 186C fluorescein-maleimide 20 
34 kd _ ~ I I i ~  
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Fig. 1. (A) SDS-PAGE (Coomassie-stained) of active, single GI30C 
mutant a-toxin (A, C) and inactive H35R GI30C double mutant (B, D), 
all labelled with acrylodan. (A,B) Purified toxins in buffer; (C,D) toxins 
bound to liposomes howing formation of the 200 kDa oligomer only 
with the active single G130C mutant oxin. (B) SDS-PAGE (UV-tran- 
silluminated) of a-toxin single mutants $69C (A) and S186C (C) as well 
as double mutants H35R $69C (B) and H35R S186C (D), all labelled 
with acrylodan and bound to liposomes. Only single mutants form 
SDS-resistant oligomers. 
tized similarly. Thus, all the hemolytically inactive toxin 
mutants were still able to bind to the membrane. 
Fig. 1A shows the results of SDS-PAGE analyses of 
active G130C and inactive H35RG130C toxins in solution 
(A, B) and after binding to liposomes (C, D), which were 
separated from unbound toxin by centrifugation. It is evi- 
dent that formation of SDS-stable oligomers occurred only 
with the active single 130C mutant, as described previ- 
ously [12,15]. Fig. 1B demonstrates the same behaviour for 
acrylodan-labelled 69 and 186 single and double mutants. 
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G130C hexamers, reisolated 
G130C on liposomes / G130C in solution 
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Fig. 2. Emission spectra of acrylodan-labelled protein with a A~x of 336 
nm. Curves are GI30C in solution, GI30C bound to liposomes, and 
GI30C oligomers after their delipidation in deoxycholate solution. Note 
partial reversibility of the blue shift in emission spectrum of the re-iso- 
lated oligomers. 
G130C on liposomes .__ .H35RG 130C on liposomes - -~  
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Fig. 3. Emission spectra of acrylodan-labelled protein with a A~x of 336 
nm. Curves are G130C in solution, GI30C bound to liposomes, H35R 
G130C bound to liposomes; the double mutant exhibited the same 
emission spectrum in solution. Note entire absence of a blue shift in 
emission spectrum of the inactive double mutant. 
These results confirm that all inactive double mutants 
behaved like the H35R mutant which was previously 
demonstrated not to form SDS-stable oligomers [8]. 
3.2. Fluorescence mission shift of acrylodan at 130C 
reflects interaction with membrane lipid 
These experiments confirmed and extended the previous 
report [12]. G130C was labelled with acrylodan and 
oligomers were isolated by gel filtration from DOC- 
solubilized liposomes. The emission spectrum of acrylodan 
was measured in comparison to membrane-bound 
oligomers and to monomeric toxin. 
As is evident from Fig. 2, the blue shift which was 
associated with oligomerization on membranes was par- 
tially reversed when membrane lipids were removed. The 
difference to unbound toxin was probably due to locally 
altered protein conformation and/or to binding of deter- 
gent [18]. We interpreted partial reversibility of the blue 
shift to imply that lipids indeed directly contribute to the 
hydrophobic environment of acrylodan in membrane-bound 
oligomers. 
3.3. Absence of oligomer formation correlates with lack of 
membrane insertion of 130C 
Acrylodan attached to different positions of the 
polypeptide chain yielded varying emission maxima, prob- 
ably reflecting influences of protein surface hydrophobic- 
ity peculiar to each microenvironment [ 12]. The results of 
experiments conducted with the labelled mutant oxins are 
summarized in Table 2, where the emission maxima of the 
different spectra re given. As reported previously [ 12], no 
change in the emission spectrum of the active $69C mu- 
tant was observed. In this study, a similar finding was 
made with the active S 186C mutant. Hence, we infer that 
residues 69 and 186 do not gain close contact with the 
hydrophobic lipid environment. This contrasts with the 
behavior of G130C where a strong blue shift in emission 
spectrum of the acrylodan occurs [12]. When the mem- 
brane-bound double mutants were analyzed, it was found 
that all three exhibited unaltered emission spectra after 
binding to the membrane. Fig. 3 shows the spectra recorded 
for the important double mutant H35R G130C. This find- 
ing indicated that lack of, or faulty oligomerization pre- 
vented the conformational change to occur that was re- 
quired for insertion of residue 130 into the bilayer. 
Table 2 
Emission spectrum axima of acrylodan-labelled proteins (Aex : 336 nm) in solution and after binding to liposomes 
Protein Unbound On membrane (oligomers) On membrane (monomers or
irregular oligomers) 
$69C 480 nm 480 nm 
H35RS69C 480 nm 480 nm 
G130C 520 nm 460 nm 
H35RGI30C 520 nm 520 nm 
S186C 475 nm 475 nm 
H35RS 186C 475 nm 475 nm 
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4. Discussion 
Formation of pores in target membranes as very wide- 
spread in biology [19]. However, progress in understanding 
the molecular events underlying this phenomenon has been 
slow because of the intrinsic difficulties in obtaining de- 
tailed structural data of these molecules in their native and 
membrane-bound state. To date, only the crystal structure 
of native aerolysin has been solved, and a working hypoth- 
esis for pore formation by this toxin based on insertion of 
amphiphilic /3-sheets from toxin oligomers into the bilayer 
has been advanced [20,21]. 
Staphylococcal a-toxin is another useful model, the 
study of which is generating concepts on the mechanism of 
pore formation by an oligomerizing toxin [1,2,5,8,12,22- 
24]. Binding of the monomers probably does not involve 
the regions around residues 69, 130 and 186, so that 
cysteines placed in these locations can be derivatized with 
fluorescent markers or biotin without marked loss of activ- 
ity [15]. H35 is also not involved in membrane-binding, 
but may be located in a domain that is critical for correct 
oligomerization to occur [8]. Work from this [2] and other 
laboratories [22] clearly indicates that proper oligomeriza- 
tion is a prerequisite to pore formation, and recent evi- 
dence indicated that the central region in a-toxin becomes 
lipid-inserted [t2]. The possibility that this central region 
might in fact be directly involved in pore formation, e.g., 
by forming at least part of the membrane-embedded chan- 
nel wall, is supported by functional studies. Thus, bio- 
chemical modifications in this region, including proteolytic 
nicking, or creation of gaps or overlaps, all cause alter- 
ations in functional pore characteristics [24,25]. Introduc- 
tion of histidine residues 130 through 134 creates channels 
that are sensitive to micromolar concentrations of zinc 
ions, which implies that those histidines are located close 
to each other at a functionally critical site of the pore, most 
probably its inner surface. In the present study, we sought 
to directly determine whether oligomerization triggered the 
insertion process, and whether insertion of 130C correlated 
with pore formation. Since replacement of H35 with argi- 
nine abrogated both oligomerization and lytic activity, we 
produced double H35R mutants containing cysteines at 
positions 69, 130 and 186. As expected, all three double 
mutants lacked oligomerization and lytic activity [8], but 
they retained their binding capacity even after attachment 
of labels at their sulfhydryl groups. We extended our 
previous observation with 130C toxin by showing that the 
blue shift exhibited by this active mutant after interaction 
with lipid was reversible following the removal of the 
lipids. This lent credence to the contention that the shift in 
emission spectrum indeed reflected a movement of Cys-130 
into the hydrophobic membrane interior. The experiments 
with the double mutant yielded clear results, and no changes 
in fluorescence emission spectrum were observed between 
the membrane-bound and free toxin. The interpretation 
with regard to 130C is thus straightforward and our data 
indicate that proper oligomerization triggers insertion of 
the central region of the molecule into the bilayer. More- 
over, lack of insertion parallels absence of pore formation, 
so that this domain indeed may form part if not all of the 
membrane-embedded pore. As discussed previously, only 
a very small part of the a-toxin molecule probably actually 
enters the membrane [2,26]. Ultrastructural measurements 
show that most of the oligomer is located outside the 
bilayer [2]. As a correlate, the sulfhydryl groups of 69C 
and 186C toxin remain accessible at the extracellular 
surface of osmotically protected cells [15]. This previous 
finding is in line with the present contention that the lack 
of a blue-shift ruly indicates lack of membrane-insertion. 
It is notable that CD measurements indicate no significant 
changes in overall structure in monomeric and oligomeric 
toxin [22,27], again in accord with the model that predicts 
participation of only small and discrete domains in pore- 
formation. Insertion of just 1-2 amphiphilic regions from 
each of the 6 toxin molecules contained in a pore-forming 
ring structure would theoretically suffice to build the walls 
of a small channel approximately 1 nm in diameter. The 
central, glycine-rich region is now emerging as a prime 
candidate for such a membrane-spanning domain, whereby 
one unexpected point is noteworthy. It could be anticipated 
that a domain predestined to enter the bilayer should be 
hidden in the native molecule, and might spontaneously 
associate with lipid once the monomer has gained close 
contact with the membrane. However, the region around 
Cys-130 is accessible to proteinases, and Cys-130 can be 
quantitatively reacted with sulfhydryl reagents in the hy- 
drophilic monomer. Even after primary binding to the 
membrane the domain remains in the hydrophilic environ- 
ment. Thus, oligomerization represents the decisive event 
leading to membrane insertion. This subtle alteration can- 
not be detected by global spectroscopic methods uch as 
measurements of circular dichroism, and the fluorimetric 
assays utilizing polarity sensitive dyes are much more 
useful in this regard. Detailed analyses of the entire do- 
main surrounding residue 130 in the a-toxin molecule may 
eventually render it possible to construct a working model 
on the molecular architecture of the membrane mbedded 
pore. 
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